Literature DB >> 12218770

Patient adherence and medical treatment outcomes: a meta-analysis.

M Robin DiMatteo1, Patrick J Giordani, Heidi S Lepper, Thomas W Croghan.   

Abstract

BACKGROUND: Adherence is a factor in the outcome of medical treatment, but the strength and moderators of the adherence-outcome association have not been systematically assessed.
OBJECTIVES: A quantitative review using meta-analysis of three decades of empirical research correlating adherence with objective measures of treatment outcomes.
METHOD: Sixty-three studies assessing patient adherence and outcomes of medical treatment were found involving medical regimens recommended by a nonpsychiatrist physician, and measuring patient adherence and health outcomes. Studies were analyzed according to disease (acute/chronic, severity), population (adult/child), type of regimen (preventive/treatment, use of medication), and type and sensitivity of adherence and outcomes measurements.
RESULTS: Overall, the outcome difference between high and low adherence is 26%. According to a stringent random effects model, adherence is most strongly related to outcomes in studies of nonmedication regimens, where measures of adherence are continuous, and where the disease is chronic (particularly hypertension, hypercholesterolemia, intestinal disease, and sleep apnea). A less stringent fixed effects model shows a trend for higher adherence-outcome correlations in studies of less serious conditions, of pediatric patients, and in those studies using self-reports of adherence, multiple measures of adherence, and less specific measures of outcomes. Intercorrelations among moderator variables in multiple regression show that the best predictor of the adherence-outcome relationship is methodological-the sensitivity/quality of the adherence assessment.

Entities:  

Mesh:

Year:  2002        PMID: 12218770     DOI: 10.1097/00005650-200209000-00009

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  415 in total

Review 1.  Factors that influence CPAP adherence: an overview.

Authors:  Gilla K Shapiro; Colin M Shapiro
Journal:  Sleep Breath       Date:  2010-07-27       Impact factor: 2.816

2.  Treating hypertension in the very elderly.

Authors:  G Michael Allan; Laurie Mallery; Noah Ivers
Journal:  Can Fam Physician       Date:  2010-11       Impact factor: 3.275

Review 3.  Neuropsychiatric complications of aging with HIV.

Authors:  Crystal C Watkins; Glenn J Treisman
Journal:  J Neurovirol       Date:  2012-05-30       Impact factor: 2.643

4.  Cost-related nonadherence by medication type among Medicare Part D beneficiaries with diabetes.

Authors:  Jessica Williams; William N Steers; Susan L Ettner; Carol M Mangione; Obidiugwu K Duru
Journal:  Med Care       Date:  2013-02       Impact factor: 2.983

Review 5.  The effect of community pharmacy-based interventions on patient health outcomes: a systematic review.

Authors:  Susan J Blalock; Andrew W Roberts; Julie C Lauffenburger; Trey Thompson; Shanna K O'Connor
Journal:  Med Care Res Rev       Date:  2012-10-02       Impact factor: 3.929

6.  Financial Incentives for Chronic Disease Management: Results and Limitations of 2 Randomized Clinical Trials With New York Medicaid Patients.

Authors:  Eric M VanEpps; Andrea B Troxel; Elizabeth Villamil; Kathryn A Saulsgiver; Jingsan Zhu; Jo-Yu Chin; Jacqueline Matson; Joseph Anarella; Patrick Roohan; Foster Gesten; Kevin G Volpp
Journal:  Am J Health Promot       Date:  2018-02-01

Review 7.  Combination drug treatment of hypertension: have we come full circle?

Authors:  Addison A Taylor
Journal:  Curr Cardiol Rep       Date:  2004-11       Impact factor: 2.931

8.  The effect of chairside chronic disease screenings by oral health professionals on health care costs.

Authors:  Kamyar Nasseh; Barbara Greenberg; Marko Vujicic; Michael Glick
Journal:  Am J Public Health       Date:  2014-02-13       Impact factor: 9.308

9.  The association between Self-Reported Medication Adherence scores and systolic blood pressure control: a SPRINT baseline data study.

Authors:  William E Haley; Olivia N Gilbert; Robert F Riley; Jill C Newman; Christianne L Roumie; Jeffrey Whittle; Ian M Kronish; Leonardo Tamariz; Alan Wiggers; Donald E Morisky; Molly B Conroy; Eugene Kovalik; Nancy R Kressin; Paul Muntner; David C Goff
Journal:  J Am Soc Hypertens       Date:  2016-09-07

10.  Generic vs brand originator alendronate: analysis of persistence and compliance in five Local Healthcare Units in the Lombardy Region of Italy.

Authors:  Giorgio L Colombo; Carlo Maurizio Montecucco
Journal:  Clin Cases Miner Bone Metab       Date:  2013-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.